BioLASCO Taiwan Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	262.66	292.5	264.72	235.91	227.58
Revenue Growth (YoY)	-10.20%	10.49%	12.21%	3.66%	-23.86%
Cost of Revenue	157.89	177.74	160.37	131.43	122.47
Gross Profit	104.78	114.76	104.35	104.49	105.11
Selling, General & Admin	56.66	59.06	53.54	55.22	51.18
Operating Expenses	56.73	59.02	53.59	55.22	51.21
Operating Income	48.04	55.74	50.76	49.27	53.89
Interest Expense	-2.03	-1.76	-1.3	-1.09	-0.88
Interest & Investment Income	1.61	2.41	1.83	0.73	0.47
Earnings From Equity Investments	0.81	1.72	8.72	4.68	2.72
Currency Exchange Gain (Loss)	-	0.18	0.31	-0.52	0.2
Other Non Operating Income (Expenses)	1.13	0.28	1.66	0.05	0.04
EBT Excluding Unusual Items	49.56	58.56	61.99	53.14	56.44
Other Unusual Items	-	-3.64	-	-	-
Pretax Income	49.56	54.92	61.99	53.14	56.44
Income Tax Expense	7.14	10.89	12.25	10.83	11.29
Earnings From Continuing Operations	42.43	44.03	49.74	42.31	45.15
Net Income	42.43	44.03	49.74	42.31	45.15
Net Income to Common	42.43	44.03	49.74	42.31	45.15
Net Income Growth	-3.63%	-11.49%	17.57%	-6.29%	-28.10%
Shares Outstanding (Basic)	26	26	26	26	26
Shares Outstanding (Diluted)	26	26	26	26	26
Shares Change (YoY)	0.24%	-0.02%	-0.00%	-0.02%	-0.03%
EPS (Basic)	1.65	1.72	1.94	1.65	1.76
EPS (Diluted)	1.65	1.72	1.94	1.65	1.76
EPS Growth	-4.02%	-11.39%	17.58%	-6.25%	-28.16%
Free Cash Flow	27.06	1.04	27.83	40.88	66.62
Free Cash Flow Per Share	1.05	0.04	1.08	1.59	2.60
Dividend Per Share	-	1.500	1.650	1.500	1.600
Dividend Growth	-	-9.09%	10.00%	-6.25%	-20.00%
Gross Margin	39.89%	39.23%	39.42%	44.29%	46.18%
Operating Margin	18.29%	19.06%	19.18%	20.88%	23.68%
Profit Margin	16.15%	15.05%	18.79%	17.94%	19.84%
Free Cash Flow Margin	10.30%	0.35%	10.51%	17.33%	29.27%
EBITDA	59.58	64.45	58.96	56.91	62.07
EBITDA Margin	22.68%	22.04%	22.27%	24.12%	27.27%
D&A For EBITDA	11.53	8.71	8.2	7.64	8.18
EBIT	48.04	55.74	50.76	49.27	53.89
EBIT Margin	18.29%	19.06%	19.18%	20.88%	23.68%
Effective Tax Rate	14.40%	19.83%	19.76%	20.38%	20.00%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.